ROME and LONDON -- Pope Francis "rested well" overnight, his 17th night in Rome's Gemelli Hospital, the Vatican said on ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

ROME -- Pope Francis "rested well" overnight, his 17th night in Rome's Gemelli Hospital, the Vatican said on Monday. "The pope rested well all night," the Holy See, the Vatican's press office, said in ...

Doctors have removed a mechanical ventilator from Pope Francis as the pontiff continues to recover from a respiratory ...

THE Vatican has released an update on Pope Francis’ health after the 88-year-old’s condition suddenly worsened in hospital.

ROME and LONDON -- Pope Francis ' clinical condition remains "stable" on Sunday, the Vatican said, as the pontiff continues ...

Pope Francis, 88, has been in hospital in Rome since February 14, suffering two respiratory crises but reported by the ...

Pope Francis slept well and has continued his treatment as usual, the Holy See press office said on Monday morning. The ...

Pope Francis remained in stable condition and did not suffer another respiratory episode a day after having "an isolated crisis of bronchospasm" that worsened his previously improving medical ...

The pope's condition remains stable yet guarded, with no ventilation needed but high-flow oxygen continuing as the Vatican monitors closely.

Pope's clinical condition remained stable as he continued treatment for bilateral pneumonia at Rome's Gemelli Hospital,' says Vatican - Anadolu Ajansı ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...